Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02045303 · ClinicalTrials.gov registry record · NA
Healing Rate of Leg Wounds Treated With Contact and Noncontact Ultrasound: The VIP Ultrasound Protocol
A NA study of Chronic Ulcer of Lower Extremity, sponsored by Texas Health Resources.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT02045303 is a NA study of Chronic Ulcer of Lower Extremity that has completed, run by Texas Health Resources. The registered enrollment target is 11 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02045303, a NA study of Chronic Ulcer of Lower Extremity, has completed, sponsored by Texas Health Resources.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
Wound healing rate is higher when contact ultrasound therapy is followed by noncontact ultrasound therapy on sub-acute and chronic lower extremity ulcers of various etiologies requiring selective debridement, as compared to either Sonoca-180 or MIST Therapy alone.
Conditions Studied
Interventions
- DEVICE Contact Ultrasound Therapy
- DEVICE Noncontact Ultrasound Therapy
Study Locations (1)
Texas
- Texas Health Resources - Presbyterian Hospital of Dallas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2014-02 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02045303
The ClinicalTrials.gov registry entry for NCT02045303 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Health Resources, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Ulcer of Lower Extremity appearing as the primary indexed condition, and to 2 interventions - of which Contact Ultrasound Therapy is the first listed.
NCT02045303 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02045303 about?
NCT02045303 is a clinical study titled "Healing Rate of Leg Wounds Treated With Contact and Noncontact Ultrasound: The VIP Ultrasound Protocol". Wound healing rate is higher when contact ultrasound therapy is followed by noncontact ultrasound therapy on sub-acute and chronic lower extremity ulcers of various etiologies requiring selective debridement, as compared to either Sonoca-180 or MIST Therapy alone.
What is the current status of trial NCT02045303?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2014-02. Estimated completion is 2015-08.
What conditions does trial NCT02045303 study?
This clinical trial studies the following conditions: Chronic Ulcer of Lower Extremity.
What interventions are being tested in trial NCT02045303?
The interventions under investigation include: Contact Ultrasound Therapy (DEVICE), Noncontact Ultrasound Therapy (DEVICE).
Who is sponsoring clinical trial NCT02045303?
This trial is sponsored by Texas Health Resources, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02045303 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Ulcer of Lower Extremity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.